Search Tag: GlaxoSmithKline plc

Executive Health Management

2021 27 Oct

Appointment further strengthens Board scientific capabilities, including in genetics which is central to GSK’s R&D approach GlaxoSmithKline plc has announced that Dr Harry (Hal) C. Dietz MD, Professor of Genetic Medicine at The Johns Hopkins University School of Medicine in the United States, will join the Board of the Company as a Non-Executive...Read more